↑Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (Sep 1997). "A model for p53-induced apoptosis". Nature. 389 (6648): 300–5. doi:10.1038/38525. PMID9305847.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Gu Z, Gilbert DJ, Valentine VA, et al. (2000). "The p53-inducible gene EI24/PIG8 localizes to human chromosome 11q23 and the proximal region of mouse chromosome 9". Cytogenet. Cell Genet. 89 (3–4): 230–3. doi:10.1159/000015620. PMID10965130.
Burns TF, Bernhard EJ, El-Deiry WS (2001). "Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo". Oncogene. 20 (34): 4601–12. doi:10.1038/sj.onc.1204484. PMID11498783.
Gentile M, Ahnström M, Schön F, Wingren S (2002). "Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis". Oncogene. 20 (53): 7753–60. doi:10.1038/sj.onc.1204993. PMID11753653.